GLORIA

GEOMAR Library Ocean Research Information Access

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 11
    Online-Ressource
    Online-Ressource
    Wiley ; 2015
    In:  Rapid Communications in Mass Spectrometry Vol. 29, No. 17 ( 2015-09-15), p. 1556-1562
    In: Rapid Communications in Mass Spectrometry, Wiley, Vol. 29, No. 17 ( 2015-09-15), p. 1556-1562
    Kurzfassung: When applying biosynthetic engineering approaches at the early stages of drug discovery, e.g. aiming to develop novel tetracycline analogues, target compounds are generally produced by engineered microorganisms in low yields. Rapid and reliable identification of metabolites with desired structural modification directly from bacterial cultures is therefore of great importance. Methods Structural elucidation of atypical tetracyclines was carried out by fragmentation applying electrospray ionisation tandem mass spectrometry (ESI‐MS/MS) (triple quadrupole – linear ion trap; Applied Biosystems 4000 QTRAP) and a high‐resolution mass spectrometer (Agilent Technologies 6224 TOF). Fragmentation patterns were obtained either with direct injection or by applying separation of target compounds with high‐performance liquid chromatography (HPLC) prior to mass spectrometry. In‐source and CID fragmentation were compared. Theoretical calculations of target structures using the Gaussian programme suite were carried out with the aim of strengthening experimental structural elucidation. Results Recombinant strains of Amycolatopsis sulphurea producing atypical tetracyclines chelocardin, modified chelocardin analogues (9‐demethylchelocardin and 2‐carboxyamido‐2‐deacetyl‐chelocardin (CDCHD), and anhydrotetracycline (ATC) were analysed by collision‐induced dissociation (CID) fragmentation with higher collision energies to yield structurally important fragments which were identified. We have demonstrated that ATC is more prone to fragmentation compared to its epimer, which was further supported by comparison of both structures calculated with ab initio calculations. Conclusions We have demonstrated that fragmentation patterns of atypical tetracyclines in CID‐MS spectra enable rapid structural elucidation of target metabolites produced by cultures of genetically engineered bacteria. This method is of significant importance for early stages of drug development considering that isolation of target metabolites produced at low concentration is challenging. Copyright © 2015 John Wiley & Sons, Ltd.
    Materialart: Online-Ressource
    ISSN: 0951-4198 , 1097-0231
    URL: Issue
    Sprache: Englisch
    Verlag: Wiley
    Publikationsdatum: 2015
    ZDB Id: 2002158-6
    ZDB Id: 58731-X
    SSG: 11
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 12
    In: Angewandte Chemie, Wiley, Vol. 127, No. 13 ( 2015-03-23), p. 4009-4012
    Kurzfassung: Antimicrobial resistance and the shortage of novel antibiotics have led to an urgent need for new antibacterial drug leads. Several existing natural product scaffolds (including chelocardins) have not been developed because their suboptimal pharmacological properties could not be addressed at the time. It is demonstrated here that reviving such compounds through the application of biosynthetic engineering can deliver novel drug candidates. Through a rational approach, the carboxamido moiety of tetracyclines (an important structural feature for their bioactivity) was introduced into the chelocardins, which are atypical tetracyclines with an unknown mode of action. A broad‐spectrum antibiotic lead was generated with significantly improved activity, including against all Gram‐negative pathogens of the ESKAPE panel. Since the lead structure is also amenable to further chemical modification, it is a platform for further development through medicinal chemistry and genetic engineering.
    Materialart: Online-Ressource
    ISSN: 0044-8249 , 1521-3757
    URL: Issue
    RVK:
    RVK:
    Sprache: Deutsch
    Verlag: Wiley
    Publikationsdatum: 2015
    ZDB Id: 505868-5
    ZDB Id: 506609-8
    ZDB Id: 514305-6
    ZDB Id: 505872-7
    ZDB Id: 1479266-7
    ZDB Id: 505867-3
    ZDB Id: 506259-7
    Standort Signatur Einschränkungen Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...